Skip to content

Medical-device intelligence

Kent Laboratories, Inc.: FDA clearances and recalls

Research Kent Laboratories, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

40 clearance records and 0 recall records in the covered releases, across 1 source company names and 28 product codes. Dated history runs from Mar 21, 1977 to Jun 1, 1995.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

40 matching records
Device / recordCompany in FDA recordSourceSource date
ANTISERUM TO HUMAN CERULOPLASMINK790714 · DDBKent Laboratories, Inc.510(k)Aug 16, 1979FDA decision date
ANTISERUM TO HUMAN FCK790715 · DASKent Laboratories, Inc.510(k)Aug 16, 1979FDA decision date
ANTISERA TO RABBIT IMMUNOGLOBULINK790720 · DFZKent Laboratories, Inc.510(k)Aug 16, 1979FDA decision date
ANTISERUM TO HUMAN ALPHA-2-MACROBLOBULINK790710 · DDYKent Laboratories, Inc.510(k)Aug 3, 1979FDA decision date
ANTISERUM TO HUMAN C-REACTIVE PROTEINSK790716 · DCNKent Laboratories, Inc.510(k)Aug 3, 1979FDA decision date
ANTISERUM, HUMAN, IGAK790703 · CZPKent Laboratories, Inc.510(k)Apr 12, 1979FDA decision date
ANTISERUM TO HUMAN IGGK790704 · DEWKent Laboratories, Inc.510(k)Apr 12, 1979FDA decision date
ANTISERUM TO HUMAN IGMK790705 · DAOKent Laboratories, Inc.510(k)Apr 12, 1979FDA decision date
ANTISERA TO HUMAN FAB FRAGMENTK771242 · DDRKent Laboratories, Inc.510(k)Aug 3, 1977FDA decision date
ANTISERA TO HUMAN FAB FRAGMENTK771243 · DFKKent Laboratories, Inc.510(k)Aug 3, 1977FDA decision date
RHODAMINE-CONJUGATED ANTISERUMK771144 · DBYKent Laboratories, Inc.510(k)Jul 14, 1977FDA decision date
FLUORESCEIN CONJUGATED ANTISERUMK770668 · DEWKent Laboratories, Inc.510(k)Apr 28, 1977FDA decision date
RHODAMINE-CONJUGATED ANTISERUMK770669 · DEWKent Laboratories, Inc.510(k)Apr 28, 1977FDA decision date
FLOR. CONJUG. HUMAN FAB FRAGMENTK770670 · DFKKent Laboratories, Inc.510(k)Apr 28, 1977FDA decision date
FLUOR. CONJUGATED ANTISERUMK770484 · DEWKent Laboratories, Inc.510(k)Mar 21, 1977FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗